Suicidal ideation in remitted major depressive disorder predicts recurrence

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Major Depressive Disorder (MDD) is a leading cause of suicide, with up to 87% of individuals affected by MDD experiencing suicidal ideation.
• The risk of recurrence in patients with remitted recurrent MDD (rrMDD) remains a significant clinical concern.
• It is unclear whether persistent suicidal symptoms during remission predict future depressive episodes.

Purpose of the Study:

• To investigate the association between baseline suicidal symptoms and recurrence in patients with rrMDD.
• To compare self-reported and clinician-rated suicidal symptoms in rrMDD patients.
• To examine the longitudinal relationship between suicidal symptoms and depressive symptomatology.

Main Methods:

• A cohort of 73 un-medicated rrMDD participants and 45 matched never-depressed controls were assessed at baseline.
• Sociodemographic characteristics and suicidal symptoms were evaluated using the Hamilton Depression Rating Scale (HDRS17) and the Inventory of Depressive Symptoms Self-Report (IDS-SR30).
• Cox regression and mixed-model analyses were employed to assess longitudinal associations between suicidal symptoms, depressive symptomatology, and MDD recurrence over a 2.5-year follow-up.

Main Results:

• rrMDD participants reported significantly higher suicidal symptoms at baseline compared to controls.
• Self-reported suicidal symptoms, unlike clinician-rated symptoms, predicted earlier MDD recurrence independently of residual depressive symptoms.
• Longitudinal analyses revealed a significant association between higher suicidal symptoms and increased depressive symptomatology.

Conclusions:

• Self-reported suicidal symptoms during remission in rrMDD are a significant predictor of recurrence, independent of residual depressive symptoms.
• Clinician-rated assessments alone may underestimate the risk of recurrence in rrMDD patients.
• Integrating self-report questionnaires for suicidal ideation into routine monitoring of rrMDD patients is recommended to better predict and manage recurrence.